Inception Return
(12/21/2012)
|
7.32 %
|
|
YTD Return
|
4.78 %
|
|
NAVPS
(10/28/2026)
|
$12.77
|
|
Change
|
($0.02) / -0.17 %
|
|
|
Growth of $10,000
(As of September 30, 2026)
|
|
MER
|
2.45 %
|
|
Assets ($mil)
|
-
|
|
Rank (1Yr)
|
1166/1719
|
|
Std Dev (3Yr)
|
6.70 %
|
|
Volatility Ranking (3Yr)
|
3/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Choice of Front or No Load
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
? Income with long term capital growth The Fund aims to generate income and long term capital growth by investing indirectly through the Partnership primarily in high-yielding equity securities and corporate bonds of North American issuers. The Fund may also invest indirectly through the Partnership primarily in securities of mutual funds. The fundamental investment objectives cannot be changed without approval of a majority of the securityholders of the Fund.
|
Fund Manager
Canoe Financial LP
Portfolio Manager
Robert J. Taylor, Canoe Financial LP
Sajan Bedi, Canoe Financial LP
Sub-Advisor
-
|
|
Asset Allocation
(As of September 30, 2026)
|
Sector Allocation
(As of September 30, 2026)
|
Geographic Allocation
(As of September 30, 2026)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Canoe Bond Advantage Fund Series A | Domestic Bonds | Fixed Income | Canada | 21.55% |
| Canoe Unconstrained Bond Fund Series I | Foreign Bonds | Fixed Income | Multi-National | 7.69% |
| Canoe Global Income Fund Series I | Foreign Bonds | Fixed Income | Multi-National | 4.71% |
| Canadian National Railway Co | Canadian Equity | Industrial Services | Canada | 3.45% |
| Tourmaline Oil Corp | Canadian Equity | Energy | Canada | 3.37% |
| Canada Government 0.00% 04-Nov-2026 | Cash and Equivalents | Cash and Cash Equivalent | Canada | 2.44% |
| Restaurant Brands International Inc | Canadian Equity | Consumer Services | Canada | 2.15% |
| Visa Inc Cl A | US Equity | Financial Services | United States | 2.12% |
| Prairiesky Royalty Ltd | Canadian Equity | Energy | Canada | 1.90% |
| Thermo Fisher Scientific Inc | US Equity | Healthcare | United States | 1.78% |
Performance Data
(As of September 30, 2026)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-3.01
|
-1.07
|
2.47
|
4.78
|
6.73
|
11.12
|
7.42
|
6.70
|
|
Benchmark
|
0.35
|
-0.75
|
9.44
|
9.10
|
9.32
|
14.97
|
7.48
|
7.52
|
|
Quartile Ranking
|
4
|
3
|
4
|
4
|
3
|
4
|
2
|
2
|
|
Calendar Return (%)
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
Fund
|
8.86
|
13.40
|
4.71
|
0.93
|
18.40
|
4.75
|
9.31
|
-3.79
|
4.62
|
8.08
|
|
Benchmark
|
10.42
|
17.48
|
11.69
|
-11.62
|
6.48
|
11.12
|
12.26
|
2.68
|
8.66
|
2.39
|
|
Quartile Ranking
|
3
|
3
|
4
|
1
|
1
|
4
|
4
|
3
|
4
|
1
|